Welcome to another episode of IQT Explains! In Part 2 of our Biotech and Investments series, we continue to explore IQT's cutting-edge work in biotechnology, focusing on our more recent investment activity and breaking down the latest developments in this ever-evolving domain. Our guests, Eugene Chiu and Dr. Michelle Rozo, delve into IQT's unique architectural approach, advancements in mRNA vaccines, gene editing, and AI-enabled biotech, as well as the challenges and opportunities ahead.

Tune in for an insightful discussion on the current biotech landscape and its impact on national security.

Key Topics

- Global Competition and U.S. Response

- Latest Developments and Innovations

- Challenges and Opportunities Ahead

- Geopolitical Influence

- Future Prospects and Potential Risks

Featured in this Episode

Farid Nemri

Program Manager

LinkedIn: https://www.linkedin.com/in/faridnemri/

Eugene Chiu

Senior Partner, Investments

LinkedIn - https://www.linkedin.com/in/eugenechiu

Dr. Michelle Rozo

VP Technology

LinkedIn - https://www.linkedin.com/in/michelle-rozo